World Health Authority: Difference between revisions
No edit summary |
No edit summary |
||
| Line 52: | Line 52: | ||
===Epidemic and Pandemic Alert and Response Center=== | ===Epidemic and Pandemic Alert and Response Center=== | ||
===Biomedical research=== | ===Biomedical tissue research=== | ||
Since 27 September 2012, and the adoption of [[General Assembly Resolution #219]], the World Health Authority has been responsible for the '''Biomedical Innovation Organisation''', and the '''Biomedical Education Organisation'''.{{Infobox WA resolution | |||
| number = 219 | |||
| organ = GA | |||
| date = 27 September | |||
| year = 2012 | |||
| code = [[General Assembly Resolution #219|GA#219]] | |||
| document = | |||
| for = 8,850 | |||
| abstention = | |||
| absent = | |||
| against = 1,130 | |||
| title = Biomedical Innovation Org | |||
| result = Adopted | |||
| status = Extant | |||
| image = | |||
| caption = | |||
}} | |||
Via the Biomedical Innovation Organisation, or '''BIO''', the WHA conducts research into, and where achievable develops, new testing regimes into biomedical tissues (i.e. viable organs, blood, and/or stem cells), that allow healthcare setting identify diseases or other defects with those biomedical tissues prior to transplantation. The BIO also has a regulatory function with regards to the application for patents for new biomedical innovations, and coordinates international research with biomedical tissue treatments, such as stem cell treatments, before disseminating information from those studies to member nations. | |||
Prior to its repeal, [[General Assembly Resolution #420]] mandated the BIO to regulate all biomedical research which it defined as "the fields of research investigating the causes of disease, disease prevention, treatment, and the mitigation or elimination of medical conditions including, but not limited to: Cancer, Paraplegia, and Motor Neuron Disease". It went on to further task the BIO with developing ethical standards for biomedical research, and to serve as an advisory institute for the many medical ethics councils located in the various member nations. The BIO was released of these particular duties when GA#420 was later repealed. | |||
GA#219 also established the Biomedical Education Organisation ('''BEO''') as a sister-agency to the BIO within the World Health Authority. The tasks associated with this child-agency, include the WHA being mandated to develop education programmes highlighting the benefits of treatment using biomedical tissue, as well as developing information campaigns designed to encourage people to to donate their own biomedical tissues to healthcare and science for treatment or research, respectively. | |||
===Commission on Biological Agents=== | ===Commission on Biological Agents=== | ||
The World Health Authority also ensures that civilians impacted by the usage and dispersal of biological agents receive the necessary treatment and assistance required as per [[General Assembly Resolution #242]]. The resolution also mandated that a World Assembly Commission on Biological Agents, or WACBA, be set up within the WHA to execute this task. The WHA is also, through WACBA, responsible for assisting member nations create and implement biosecurity protocol and defences to help ensure the safety of their populace. | The World Health Authority also ensures that civilians impacted by the usage and dispersal of biological agents receive the necessary treatment and assistance required as per [[General Assembly Resolution #242]]. The resolution also mandated that a '''World Assembly Commission on Biological Agents''', or '''WACBA''', be set up within the WHA to execute this task. The WHA is also, through WACBA, responsible for assisting member nations create and implement biosecurity protocol and defences to help ensure the safety of their populace. | ||
This remit was expanded with [[General Assembly Resolution #382]]. The ''Environmental Warfare Act'' empowers WACBA to aid civilian populations in "mitigat[ing] and revers[ing]" incidents of environmental warfare, which the resolution defines as "the intentional introduction of an invasive species into a foreign ecosystem for purposes of damaging it", and to also educate member states on the identification of invasive species. | This remit was expanded with [[General Assembly Resolution #382]]. The ''Environmental Warfare Act'' empowers WACBA to aid civilian populations in "mitigat[ing] and revers[ing]" incidents of environmental warfare, which the resolution defines as "the intentional introduction of an invasive species into a foreign ecosystem for purposes of damaging it", and to also educate member states on the identification of invasive species. | ||
| Line 62: | Line 84: | ||
In addition to its other duties and activities, the World Health Authority was further tasked with the monitoring of antibiotic and antimicrobial-resistant diseases with the adoption of [[General Assembly Resolution #333]] on 03 July 2015. | In addition to its other duties and activities, the World Health Authority was further tasked with the monitoring of antibiotic and antimicrobial-resistant diseases with the adoption of [[General Assembly Resolution #333]] on 03 July 2015. | ||
An Antimicrobial Resistance Workgroup was also established in the WHA under the conditions of GA#333, primarily responsible for the coordination of information surrounding antimicrobial resistance between World Assembly member states, as well as evaluation member nations' individual proposed response to further development and spread of such diseases in their jurisdictions. | An '''Antimicrobial Resistance Workgroup''' was also established in the WHA under the conditions of GA#333, primarily responsible for the coordination of information surrounding antimicrobial resistance between World Assembly member states, as well as evaluation member nations' individual proposed response to further development and spread of such diseases in their jurisdictions. | ||
===Animal Experimentation Board=== | ===Animal Experimentation Board=== | ||
The World Health Authority Animal Experimentation Board, or AEB, was created on 26 May 2020 with the passage of [[General Assembly Resolution #489]] to regulate and restrict the usage of animal experimentation in scientific research or product development. The resolution also explicitly tasks the AEB with working to identify alternatives to animal research, giving the body a scientific function rather than a solely regulatory or administrative one. | The '''World Health Authority Animal Experimentation Board''', or '''AEB''', was created on 26 May 2020 with the passage of [[General Assembly Resolution #489]] to regulate and restrict the usage of animal experimentation in scientific research or product development. The resolution also explicitly tasks the AEB with working to identify alternatives to animal research, giving the body a scientific function rather than a solely regulatory or administrative one. | ||
In addition to its supervisory and research duties, the AEB is also tasked with referring institutions who do not comply with the resolution to the [[World Assembly Compliance Commission]]; all institutions or companies that use animal research in line with the provisions of the resolution are required to report such instances of animal use to the AEB, who then makes an initial determination as to whether or not the resolution was complied with. | In addition to its supervisory and research duties, the AEB is also tasked with referring institutions who do not comply with the resolution to the [[World Assembly Compliance Commission]]; all institutions or companies that use animal research in line with the provisions of the resolution are required to report such instances of animal use to the AEB, who then makes an initial determination as to whether or not the resolution was complied with. | ||
===World Medications Council=== | ===World Medications Council=== | ||
[[General Assembly Resolution #582]] established the World Medications Council (WMC) under the auspices of the WHA on 31 October 2021. Via this child agency, the WHA was tasked with the mission of improving access to safe, cost-effective, and efficacious medicine in all member nations. This resolution tasked the WMC with creating and maintaining an Effective Medications List; essentially, amongst other things, compiling a list of medicines, their use and prescription properties (including dosage), and their cost points to disseminate to member nations. | [[General Assembly Resolution #582]] established the '''World Medications Council''' ('''WMC''') under the auspices of the WHA on 31 October 2021. Via this child agency, the WHA was tasked with the mission of improving access to safe, cost-effective, and efficacious medicine in all member nations. This resolution tasked the WMC with creating and maintaining an Effective Medications List; essentially, amongst other things, compiling a list of medicines, their use and prescription properties (including dosage), and their cost points to disseminate to member nations. | ||
The WHA was also, through the WMC, tasked with assessing the safety and efficacy of all medicines, current and future, making it the international agency responsible for the regulation and supervision of the use and distribution of therapeutic and pharmaceutical products in all member states. | The WHA was also, through the WMC, tasked with assessing the safety and efficacy of all medicines, current and future, making it the international agency responsible for the regulation and supervision of the use and distribution of therapeutic and pharmaceutical products in all member states. | ||
Revision as of 14:26, 23 December 2021
 | |
 WHA Flag | |
| Abbreviation | WHA |
|---|---|
| Formation | January 6, 2009; 17 years, 149 days |
| Type | World Assembly agency |
| Legal status | Active |
| Headquarters | WA Headquarters |
The World Health Authority, or WHA, is an agency of the World Assembly (WA) based at the WA Headquarters in sovereign WA territory. Its stated purpose at its creation was to monitor, identify, and manage threats to global health, and to coordinate international response to threats to public health. Since then, additional duties have been added to its remit by the General Assembly, with various pieces of legislation also creating child agencies of the WHA which are tasked with specific responsibilities.
The WHA maintains offices in most World Assembly member nations, with some more specialised tasks forces located in nations experiencing significant public health issues, or other problems under the purview of the WHA or its child agencies. As with other World Assembly agencies, all member states are under the responsibility of the World Health Authority.
History
The World Health Authority was established upon the passage of General Assembly Resolution #31 on 06 January 2009. Proposed by the delegation from the nation of Belarum, it followed a number of resolutions concerned with the health and wellbeing of people within World Assembly member states, including on topics such as the coordination of relief aid[1], the transportation of medical aid and supplies[2], and regulations on the treatment of the ill in member states' territory[3].
| WA General Assembly Resolution 31 | |
|---|---|
| Date | 06 January 2009 |
| Code | GA#31 |
| Title | World Health Authority |
Voting summary | 3,284 voted for 838 voted against |
| Result | Adopted |
| Status | Extant |
The WHA was originally tasked with a very limited and defined mission, namely:
- to identify, assess, and communicate current and emerging threats to global health;
- to actively research treatment, cures, and preventative measures concerning threats to global health; and,
- to coordinate efforts between WA member states in preventing and controlling serious health concerns.
The World Health Authority was originally intended as a replacement for the defunct United Nations Center for Disease Prevention and Control, which had ceased to exist upon the collapse of the United Nations, and indeed has the very same similar aims. However, later delegations built upon this basic foundation and added more responsibilities, such as biomedical education and innovation, and regulation for animal experimentation among others.
Activities
Health Research & Development Division
Epidemic and Pandemic Alert and Response Center
Biomedical tissue research
Since 27 September 2012, and the adoption of General Assembly Resolution #219, the World Health Authority has been responsible for the Biomedical Innovation Organisation, and the Biomedical Education Organisation.
| WA General Assembly Resolution 219 | |
|---|---|
| Date | 27 September 2012 |
| Code | GA#219 |
| Title | Biomedical Innovation Org |
Voting summary | 8,850 voted for 1,130 voted against |
| Result | Adopted |
| Status | Extant |
Via the Biomedical Innovation Organisation, or BIO, the WHA conducts research into, and where achievable develops, new testing regimes into biomedical tissues (i.e. viable organs, blood, and/or stem cells), that allow healthcare setting identify diseases or other defects with those biomedical tissues prior to transplantation. The BIO also has a regulatory function with regards to the application for patents for new biomedical innovations, and coordinates international research with biomedical tissue treatments, such as stem cell treatments, before disseminating information from those studies to member nations.
Prior to its repeal, General Assembly Resolution #420 mandated the BIO to regulate all biomedical research which it defined as "the fields of research investigating the causes of disease, disease prevention, treatment, and the mitigation or elimination of medical conditions including, but not limited to: Cancer, Paraplegia, and Motor Neuron Disease". It went on to further task the BIO with developing ethical standards for biomedical research, and to serve as an advisory institute for the many medical ethics councils located in the various member nations. The BIO was released of these particular duties when GA#420 was later repealed.
GA#219 also established the Biomedical Education Organisation (BEO) as a sister-agency to the BIO within the World Health Authority. The tasks associated with this child-agency, include the WHA being mandated to develop education programmes highlighting the benefits of treatment using biomedical tissue, as well as developing information campaigns designed to encourage people to to donate their own biomedical tissues to healthcare and science for treatment or research, respectively.
Commission on Biological Agents
The World Health Authority also ensures that civilians impacted by the usage and dispersal of biological agents receive the necessary treatment and assistance required as per General Assembly Resolution #242. The resolution also mandated that a World Assembly Commission on Biological Agents, or WACBA, be set up within the WHA to execute this task. The WHA is also, through WACBA, responsible for assisting member nations create and implement biosecurity protocol and defences to help ensure the safety of their populace.
This remit was expanded with General Assembly Resolution #382. The Environmental Warfare Act empowers WACBA to aid civilian populations in "mitigat[ing] and revers[ing]" incidents of environmental warfare, which the resolution defines as "the intentional introduction of an invasive species into a foreign ecosystem for purposes of damaging it", and to also educate member states on the identification of invasive species.
Antimicrobial Resistance
In addition to its other duties and activities, the World Health Authority was further tasked with the monitoring of antibiotic and antimicrobial-resistant diseases with the adoption of General Assembly Resolution #333 on 03 July 2015.
An Antimicrobial Resistance Workgroup was also established in the WHA under the conditions of GA#333, primarily responsible for the coordination of information surrounding antimicrobial resistance between World Assembly member states, as well as evaluation member nations' individual proposed response to further development and spread of such diseases in their jurisdictions.
Animal Experimentation Board
The World Health Authority Animal Experimentation Board, or AEB, was created on 26 May 2020 with the passage of General Assembly Resolution #489 to regulate and restrict the usage of animal experimentation in scientific research or product development. The resolution also explicitly tasks the AEB with working to identify alternatives to animal research, giving the body a scientific function rather than a solely regulatory or administrative one.
In addition to its supervisory and research duties, the AEB is also tasked with referring institutions who do not comply with the resolution to the World Assembly Compliance Commission; all institutions or companies that use animal research in line with the provisions of the resolution are required to report such instances of animal use to the AEB, who then makes an initial determination as to whether or not the resolution was complied with.
World Medications Council
General Assembly Resolution #582 established the World Medications Council (WMC) under the auspices of the WHA on 31 October 2021. Via this child agency, the WHA was tasked with the mission of improving access to safe, cost-effective, and efficacious medicine in all member nations. This resolution tasked the WMC with creating and maintaining an Effective Medications List; essentially, amongst other things, compiling a list of medicines, their use and prescription properties (including dosage), and their cost points to disseminate to member nations.
The WHA was also, through the WMC, tasked with assessing the safety and efficacy of all medicines, current and future, making it the international agency responsible for the regulation and supervision of the use and distribution of therapeutic and pharmaceutical products in all member states.